Search results - 6 results
Prevalence Estimation Of HCV Among People Who Inject Drugs In Belgium Through Respondent Driven Sampling, Capture-Recapture And Multiplier Method
multiplied with the result of the CRC. Results: Approximately 43.4% (95% CI 28.9% – 58.0%) of the PWID tested positive for HCV antibodies in Brussels. This corresponds to 304 (95% CI 160 – 547) PWID in ...
Hepatitis C virus prevalence in Belgium
0.02% (95% CI 0.00–0.07%). The results show a much lower HCV seroprevalence compared to previous studies. Health Topics: Hepatitis A, B, C, D en E Hepatitis A, B, C, D and E Hépatites A, B, C, D et ...
Hepatitis C virus prevalence in Belgium
0.02% (95% CI 0.00–0.07%). The results show a much lower HCV seroprevalence compared to previous studies. Health Topics: Hepatitis A, B, C, D and E Hépatites A, B, C, D et E Hepatitis A, B, C, D en ...
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
clustered sampling. RESULTS: In total 3209 specimens, collected by 28 laboratories, were tested. HCV seropositivity in the Belgian general population was estimated to be 0.22% (95% CI: 0.09-0.54%), and prevalence of ...
Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method
CI 538 – 935) for Brussels and between 6,620 (95% CI 4,711 – 8,576) and 7,018 (95% CI 4,794 – 9,527) for Belgium. Conclusions These estimates provide crucial information to ensure that services to PWID ...
Stable HEV IgG seroprevalence in Belgium between 2006 and 2014.
rate of 54,352) (sero-)infections were found between 2006 and 2014. Overall, HEV IgG seroprevalences were 4.1% (64/1579, 95% CI 3.1-5.1) and 5.8% (12½087, CI 4.8-6.9) in 2006 and 2014, respectively. ...